Corrigendum to "Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers" [Vaccine 26 (2008) 6671-6677] (DOI:10.1016/j.vaccine.2008.09.016)

Guimarães-Walker, A; Mackie, N; McCormack, S; Hanke, T; Schmidt, C; Gilmour, J; Barin, B; McMichael, A; Weber, J; Legg, K; Babiker, A; Hayes, P; Gotch, F; Smith, C; Dally, L; Dorrell, L; Cebere, I; Kay, R; Winstone, N; Moore, S; Goonetilleke, N; Fast, P

Journal article

Corrigendum to "Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers" [Vaccine 26 (2008) 6671-6677] (DOI:10.1016/j.vaccine.2008.09.016)

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Guimarães-Walker, A., Mackie, N., McCormack, S., Hanke, T., Schmidt, C., Gilmour, J., Barin, B., McMichael, A., Weber, J., Legg, K., Babiker, A., Hayes, P., Gotch, F., Smith, C., Dally, L., Dorrell, L., Cebere, I., Kay, R., Winstone, N., … Fast, P. (2011). Corrigendum to "Lessons from IAVI-006, a Phase I clinical trial to evaluate the safety and immunogenicity of the pTHr.HIVA DNA and MVA.HIVA vaccines in a prime-boost strategy to induce HIV-1 specific T-cell responses in healthy volunteers" [Vaccine 26 (2008) 6671-6677] (DOI:10.1016/j.vaccine.2008.09.016). Vaccine.

MLA Style

Guimarães-Walker, A., et al. “Corrigendum to ‘Lessons from IAVI-006, a Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the PTHr.HIVA DNA and MVA.HIVA Vaccines in a Prime-Boost Strategy to Induce HIV-1 Specific T-Cell Responses in Healthy Volunteers’ [Vaccine 26 (2008) 6671-6677] (DOI:10.1016/J.vaccine.2008.09.016).” Vaccine, 2011.

Chicago Style

Guimarães-Walker, A, N Mackie, S McCormack, T Hanke, C Schmidt, J Gilmour, B Barin, et al. 2011. “Corrigendum to ‘Lessons from IAVI-006, a Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of the PTHr.HIVA DNA and MVA.HIVA Vaccines in a Prime-Boost Strategy to Induce HIV-1 Specific T-Cell Responses in Healthy Volunteers’ [Vaccine 26 (2008) 6671-6677] (DOI:10.1016/J.vaccine.2008.09.016).” Vaccine.
Tweet
Print